Shock/Sepsis/Trauma/Critical CareProtective effects of syringin against lipopolysaccharide-induced acute lung injury in mice
Introduction
Acute lung injury (ALI) is a critical illness syndrome with high morbidity and mortality in critically ill patients.1 ALI is characterized by severe lung inflammation and increased capillary permeability.2 Lipopolysaccharide (LPS) has been identified as the major factor that leads to ALI.3 In mice with ALI, LPS significantly upregulates the expression of inflammatory cytokines tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6.4 Studies showed that these cytokines cause the aggregation of neutrophilic leukocytes and lead to lung injury.5 Therefore, inhibition of these cytokines has drawn a great attention in the treatment of LPS-induced ALI. Nuclear factor κB (NF-κB) is a nuclear transcription factor, which plays an important role in the regulation of inflammatory cytokines.6, 7 Inhibition of NF-κB activation has the ability to attenuate LPS-induced ALI.8, 9
Syringin is a major active substance isolated from Eleutherococcus senticosus. It has been found that syringin has broad pharmacologic effects, such as anti-inflammatory and antinociceptive effects.10 Syringin has been reported to protect against LPS and D-galactosamine–induced hepatic failure.11 Syringin also inhibits LPS-induced TNF-α production in RAW264.7 cells.12 Furthermore, syringin has been reported to exert sleep-potentiating effects through the nitric oxide synthases–nitric oxide pathway.13 However, the effects of syringin on LPS-induced ALI have not been reported. Therefore, in this study, we investigated the effects of syringin on LPS-induced ALI in mice.
Section snippets
Reagents
Mouse TNF-α, IL-6, and IL-1β enzyme-linked immunosorbent assay (ELISA) kits were purchased from BioLegend (San Diego, CA). The myeloperoxidase (MPO) determination kit was purchased by the Jiancheng Bioengineering Institute of Nanjing (Jiangsu, China). Mouse nuclear factor-erythroid 2-related factor-2 (Nrf2), HO-1, NF-κB p65, NF-κB p-p65, IκB, p-IκB, and β-actin were provided from Cell Signaling Technology Inc (Beverly, MA). Syringin was purchased from Chengdu Must Bio-technology Co, Ltd
Syringin reduces LPS-induced lung edema in mice
Lung W/D ratio was used to assess the effects of syringin on lung edema. As shown in Figure 1, the lung W/D ratio was dramatically higher after LPS challenged compared with the control group. However, the increase induced by LPS was dose dependently inhibited by treatment of syringin.
Syringin ameliorates LPS-induced MPO activity and MDA content
MPO activity and MDA content were used to assess the neutrophil accumulation and the oxidative stress within lung tissues. In this study, our results showed that the MPO activity and MDA content increased
Discussion
LPS-induced ALI is characterized by severe inflammatory response in lung tissues. Syringin has been reported to have anti-inflammatory effects. However, whether syringin has anti-inflammatory effects on LPS-induced ALI remains unclear. Here, we attempted to investigate the effects of syringin on LPS-induced ALI in mice.
LPS-induced ALI model in mice is characterized by the intra-alveolar and interstitial edema, alveolar hemorrhage, and overwhelming lung inflammation, which ideally imitate the
Acknowledgment
Authors' contributions: A.Z. and H.W. contributed to the conception and design. A.Z. and Z.L. did the analysis and interpretation. L.S. did the data collection. A.Z. and H.W. wrote the article and did the critical revision of the article.
References (34)
- et al.
Cytokine-mediated inflammation in acute lung injury
Cytokine Growth Factor Rev
(2003) - et al.
Protective effect of catalpol on lipopolysaccharide-induced acute lung injury in mice
Int Immunopharmacol
(2014) - et al.
Tenuigenin ameliorates acute lung injury by inhibiting NF-kappa B and MAPK signalling pathways
Respir Physiol Neurobiol
(2015) - et al.
Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury
Cell
(2008) Oxidative stress and lung inflammation in airways disease
Eur J Pharmacol
(2001)- et al.
Heme oxygenase-1 upregulation significantly inhibits TNF-alpha and Hmgb1 releasing and attenuates lipopolysaccharide-induced acute lung injury in mice
Int Immunopharmacol
(2008) - et al.
Wogonoside protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-kappaB and NLRP3 inflammasome activation
Biochem Pharmacol
(2015) - et al.
LPS/TLR4 signal transduction pathway
Cytokine
(2008) - et al.
Penehyclidine hydrochloride attenuates LPS-induced acute lung injury involvement of NF-kappaB pathway
Pharmacol Res
(2009) - et al.
NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease
Trends Mol Med
(2011)